RSP Successfully Closes EUR 17 million Series C Capital Raise
We are proud to share that RSP Systems has successfully closed its Series C investment round at its hard cap of EUR 17 million. This capital injection will continue to support RSP’s fast-paced growth to delivering the world’s first non-invasive wearable glucose monitor. The financing round is the latest in a series of successful capital […]
Calibration of a non-invasive Raman spectroscopy device realized using pre-collected clinical data
Recent Clinical Results Revealed at ATTD 2024
At this year’s ATTD conference in Florence, RSP Systems shared recent findings from our latest clinical study, namely RSP-26, showcasing that non-invasive monitoring of glucose levels in people with type 2 diabetes is now possible and efficient following only a short initial calibration. Historically, the calibration stability and accuracy required for non-invasive glucose monitoring have […]
Explore Our Latest Innovation at ATTD 2024
From 6-9 March this year, RSP Systems will be participating in the 17th annual International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Florence, Italy. Our adept team present at this important event will include Anders Weber (CEO), Stine Dahl (CFO/COO), Kaspar Rasmussen (Senior Data Science Specialist) and Markus Rasmussen (Machine Learning Specialist). You will be able […]
Rapid Advancements in Technology Miniaturization
As pioneers within our field, we have successfully demonstrated the ability to monitor – completely non-invasively – and track glucose levels over an extended period of time 1,2. This breakthrough has not only expanded our knowledge but also enabled us to refine our technology, resulting in the miniaturisation of the individual components. We are now […]
Stine Holst Madsen
Lead Regulatory Affairs Specialist
Publication of Clinical Results in ACS Sensors
Findings in clinical studies indicate that the combination of Raman Spectroscopy with multivariate data analysis, is the best fit for at-home non-invasive monitoring of glucose levels in people with diabetes. At RSP, we are not only demonstrating that Raman can measure glucose accurately and pain-free, but also that it provides stable calibration for a long […]
RSP Systems is Joining ATTD 2023 in Berlin
From the 22nd-25th of February, RSP Systems will be in Berlin attending the 16th annual conference on Advanced Technologies & Treatments for Diabetes (ATTD). The innovation within the field of diabetes treatments and technologies is evolving forward at full speed. The ATTD conference is a unique internationally recognized event that provides a world-class platform for […]
A Strong Partnership Announcement – Trumpf Photonics
RSP Systems is proud to announce that we have entered the new year with a strong partnership with Trumpf Photonics. Since the introduction of CGM more than 20 years ago, people with diabetes have searched for a more convenient solution to manage their disease. At RSP Systems, we are developing the world’s first non-invasive glucose […]
Raman is the Solution For Non-Invasive, Continuous Glucose Monitoring
Sampling blood using finger pricks or the insertion of electrochemical devices into the skin are the two invasive and intrusive choices facing a person with diabetes today. A recently published paper by Todaro et. al. has reviewed the extensive field of technologies aiming to realize non-invasive glucose monitoring, and points to Raman technology combined with […]
